Ming Jiang

机构：Guilin Medical University, Sichuan University, Sichuan Cancer Hospital · ORCID：0000-0001-6794-3116

发表论文 85 篇 · 总被引 1938 次 · h-index 18

代表论文

• FATP2 activates PI3K/Akt/mTOR pathway by inhibiting ATF3 and promotes the occurrence and development of bladder cancer (2024 · Cellular Signalling · 被引 17)
• MTX-211 Inhibits GSH Synthesis through Keap1/NRF2/GCLM Axis and Exerts Antitumor Effects in Bladder Cancer (2023 · International Journal of Molecular Sciences · 被引 16)
• Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase‐targeted protein degrader BGB‐16673 (2024 · British Journal of Pharmacology · 被引 12)
• Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer (2023 · International Journal of General Medicine · 被引 11)
• EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer (2023 · PeerJ · 被引 8)
• Comprehensive analysis of the expression, prognostic value and biological importance of OVO‑like proteins in clear cell renal cell carcinoma (2023 · Oncology Letters · 被引 7)